Clostridium difficile infection (‘CDI’) is a major healthcare issue in hospitals, long-term care homes, and increasingly in the wider community. It is a serious illness caused by infection of the colon by the bacteria, C. difficile, which produces toxins that cause inflammation, severe diarrhoea and can in the most serious of cases be fatal.Read More
Result of General Meeting
On 2 February 2015, we announced a proposed US offering of American Depositary Shares and a listing on the NASDAQ Global Market.
A General Meeting of shareholders was held on 19 February at which all the resolutions were passed.
The full details of the proxy votes cast are now available from our Investors section.
Duchenne Muscular Dystrophy (‘DMD’) is a fatal, genetic disease that predominantly affects boys. It has a population of around 50,000 in the developed world and is classified as a rare or orphan disease. DMD is caused by the absence of a protein called dystrophin which is essential in maintaining the healthy function of muscles in the body.
Currently there is no disease modifying treatment for all patients with DMD.Read More